Magnetic resonance imaging of the right ventricle in pediatric pulmonary arterial hypertension

Pulmonary Circulation

Volumn 3, Issue 2, 2013, Pages 350-355

  Blalock, Shannon ^a   Chan, Frandics ^b   Rosenthal, David ^b   Ogawa, Michelle ^b   Maxey, Dawn ^b   Feinstein, Jeffrey ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Cardiac magnetic resonance; Pediatrics; Pulmonary hypertension; Right ventricle

Indexed keywords

EID: 84923093150     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.4103/2045-8932.114763     Document Type: Article

References (22)

1. Chin KM, Kim NH, Rubin LJ. The right ventricle in pulmonary hypertension. Coron Artery Dis 2005;16:13-8.
2. Barst RJ, Ertel SI, Beghetti M, Ivy DD. Pulmonary arterial hypertension: A comparison between children and adults. Eur Respir J 2011;37:665-77.
3. D’Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115:343-9.
4. Haworth SG, Hislop AA. Treatment and survival in children with pulmonary arterial hypertension: The UK Pulmonary Hypertension Service for Children 2001-2006. Heart 2009;95:312-7.
5. Ivy DD, Rosenzweig EB, Lemarie JC, Brand M, Rosenberg D, Barst RJ. Longterm outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings. Am J Cardiol 2010;106:1332-8.
6. Badano LP, Ginghina C, Easaw J, Murraru D, Grillo MT, Lancellotti P, et al. Right ventricle in pulmonary arterial hypertension: Haemodynamics, structural changes, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effects. Eur J Echocardiogr 2010;11:27-37.
7. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Lyod JE, Manes A, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54:S55-66.
8. van Wolferen SA, Marcus JT, Boonstra A, Marques KM, Bronzwaer JG, Spreeuwenberg MD, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007;28:1250-7.
9. van Wolferen SA, van de Veerdonk MC, Mauritz GJ, Jacobs W, Marcus JT, Marques KM, et al. Clinical significant change of stroke volume in pulmonary hypertension. Chest 2010;139:1003-9.
10. Van Praagh S, Geva T, Lock JE, Nido PJ, Vance MS, Van Praagh R. Biatrial or left atrial drainage of the right superior vena cava: Anatomic, morphogenetic, and surgical considerations: Report of three new cases and literature review. Pediatr Cardiol 2003;24:350-63.
11. Fakhri AA, Hughes-Doichey RA, Beiderman RW, Murali S. Imaging in the evaluation of pulmonary artery hemodynamics and right ventricular structure and function. Heart Fail Clin 2012;8:353-72.
12. Sarikouch S, Peters B, Gutberlet M, Leismann B, Kelter-Kloepping A, Koerperich H, et al. Sex-specific pediatric percentiles for ventricular size and mass as reference values for cardiac MRI: Assessment by steady-state freeprecession and phase-contrast MRI flow. Circ Cardiovasc Imaging 2010;3:65-76.
13. Mauritz GJ, Marcus JT, Boonstra A, Postmus PE, Westerhof N, Vonk-Noordegraaf A. Non-invasive stroke volume assessment in patients with pulmonary arterial hypertension: Left-sided data mandatory. J Cardiovasc Magn Reson 2008;10:51.
14. Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 2005;7:775-82.
15. Wilmore J, Hamra M. Physiology of Exercise in Children. In: The Science and Practice of Pediatric Cardiology. 2nd ed, Vol 1. Baltimore, Maryland: Williams and Wilkins; 1998. p. 447.
16. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
17. Lammers AE, Hislop AA, Flynn Y, Haworth SG. The 6-minute walk test: Normal values for children of 4-11 years of age. Arch Dis Child 2008;93:464-8.
18. Blyth KG, Groenning BA, Martin TN, Foster JE, Mark PB, Dargie HJ, et al. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 2005;26:1993-9.
19. McCann GP, Beek AM, Vonk-Noordegraaf A, van Rossum AC. Delayed contrast-enhanced magnetic resonance imaging in pulmonary arterial hypertension. Circulation 2005;112:e268.
20. McCann GP, Gan CT, Beek AM, Niessen HW, Vonk Noordegraaf A, van Rossum AC. Extent of MRI delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension. AJR Am J Roentgenol 2007;188:349-55.
21. Chin KM, Kingman M, de Lemos JA, Warner JJ, Reimond S, Peshock R, et al. Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension. Am J Cardiol 2008;101:1669-72.
22. Haworth SG, Beghetti M. Assessment of endpoints in the pediatric population: Congenital heart disease and idiopathic pulmonary arterial hypertension. Curr Opin Pulm Med 2010;16 Suppl 1:S35-41